62
Participants
Start Date
March 17, 2021
Primary Completion Date
July 29, 2022
Study Completion Date
July 29, 2022
Enoblituzumab
Anti-B7-H3 antibody
Retifanlimab
Anti-PD-1 antibody
Tebotelimab
PD-1 X LAG-3 bispecific DART molecule
Uzsoki Street Hospital, Budapest
MHAT Nadezhda, Medical Oncology, Sofia
UMHAT Tsarisa Yoanna - ISUL, Sofia
MHAT Serdica, Panagyurishte
Royal North Shore Hospital, Sydney
Liverpool Hospital, Liverpool
Calvary Mater Newcastle, Waratah
Monash Health, Medical Oncology Department, Ruse
Andrew Love Cancer Centre, Barwon Health, Geelong
Icon Cancer Centre Southport, Southport
MBAL Uni Hospital, Pleven
Dept of Oncology, Bekec County Hosp, Gyula
UMHAT Georgi Stranski Medical Oncology Department, Sofia
Fiona Stanley Hospital, Murdoch
Complex Oncology Center Ruse Ltd., Dobrich
Dept of Oncology, Tolna County Hospital, Szekszárd
COC Dobrich, Sofia
The Ewa Pilecka Department of Clinical Oncology, Bialystok
University of Pittsburgh Medical Center- Hillman Cancer Center, Pittsburgh
University of Pennsylvania - Abramson Cancer Center, Philadelphia
Communal Nonprofit Enterprise Podilsky Regional Center of Oncology, Vinnytsia
University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
"Communal Non-profit Enterprise Regional Clinical Oncology Center of Kirovohrad Regional Council,", Kropyvnytskyi
University of North Carolina - Lineberger Cancer Center, Chapel Hill
Hospital Clínico San Carlos, Madrid
Clinica Universidad de Navarra, Pamplona
"Municipal Non-Profit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary", Sumy
Hospital Universitario Virgen de la Macarena, Seville
University of Michigan, Ann Arbor
"Communal Non-profit Enterprise City Clinical Hospital#4 of Dnipro City", Dnipro
"Communal Non-Profit Enterprise Regional Center of Oncology, Oncosurgical Department of Head and Neck", Kharkiv
Comprehensive Cancer Centers of Nevada, Las Vegas
Bajcsy-Zsilinszky Korhaz, Budapest
Dept of Oncology, University of Debrecen, Debrecen
Uniwersyteckie Centrum Kliniczne, Gdansk
I Clinics of Radiotherapy and Chemiotherapy; The Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice
Biokinetica, Józefów
Clinics of Head and Neck Cancer, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
Complejo Hospitalario Universitario de Badajoz, Badajoz
Hospital Universitario Vall D'Hebrón, Barcelona
Hospital Clínic de Barcelona, Barcelona
Kyiv City Clinical Oncological Centre, Kyiv
Lead Sponsor
MacroGenics
INDUSTRY